Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum

A case is reported of a 21 year old woman who suffered from Castleman's disease and systemic reactive amyloidosis. The serum concentrations of serum amyloid A (SAA) and interleukin 6 (IL-6) were extremely high and amyloid protein was immunohistochemically identified as AA. After surgical excisi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical pathology 1997-11, Vol.50 (11), p.965-967
Main Authors: Ikeda, S, Chisuwa, H, Kawasaki, S, Ozawa, J, Hoshii, Y, Yokota, T, Aoi, T
Format: Article
Language:English
Subjects:
Adult
Amyloidosis - blood
Amyloidosis - etiology
Biological and medical sciences
Castleman Disease - blood
Castleman Disease - complications
Castleman Disease - pathology
Female
Hematologic and hematopoietic diseases
Humans
Interleukin-6 - blood
Medical sciences
Other diseases. Hematologic involvement in other diseases
Serum Amyloid A Protein - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b509t-23cf05c46f4bf2c5f750345b203f69c5e6507cae3839e54aa49736d5f2cbff473
cites cdi_FETCH-LOGICAL-b509t-23cf05c46f4bf2c5f750345b203f69c5e6507cae3839e54aa49736d5f2cbff473
container_end_page 967
container_issue 11
container_start_page 965
container_title Journal of clinical pathology
container_volume 50
creator Ikeda, S
Chisuwa, H
Kawasaki, S
Ozawa, J
Hoshii, Y
Yokota, T
Aoi, T
description A case is reported of a 21 year old woman who suffered from Castleman's disease and systemic reactive amyloidosis. The serum concentrations of serum amyloid A (SAA) and interleukin 6 (IL-6) were extremely high and amyloid protein was immunohistochemically identified as AA. After surgical excision of a large retroperitoneal lymph node with the pathological findings of plasma cell type of Castleman's disease, both serum SAA and IL-6 declined, showing a similar pattern of reduction curves. All clinical symptoms and laboratory abnormalities greatly improved. The biochemical feature of Castleman's disease is abnormal production of IL-6 and this cytokine continuously may stimulate the synthesis of an amyloid precursor, SAA, causing systemic reactive (AA) amyloidosis. This pathogenetic theory is strongly supported by the present study.
doi_str_mv 10.1136/jcp.50.11.965
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_500328</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3971438511</sourcerecordid><originalsourceid>FETCH-LOGICAL-b509t-23cf05c46f4bf2c5f750345b203f69c5e6507cae3839e54aa49736d5f2cbff473</originalsourceid><addsrcrecordid>eNqFkkuP0zAUhSMEGoaBJUskSyBgk-LErwaJxajiXUCCga11495M3UnsYjsD_Tn8U9xpKY8NKz_Od-491nVR3K3opKqYfLIy64nY7ieNFNeK44qruuQVl9eLY0rrqmwUlzeLWzGuKK2YqthRcdRwWdeCHRc_Pm1iwsEaEhBMspdIYNj03i58tJFAjN5YSLgg32xakhnE1OMA7lEkCxsRIj4lEYOFnpgluHOMxHckLZEY7wy6FCBZ765uwYwJyXqZTVvPOPxqRU4JuAWxLmHocbywjsh82kG3ixsd9BHv7NeT4vOL52ezV-X8w8vXs9N52QrapLJmpqPCcNnxtquN6JSgjIu2pqyTjREoBVUGkE1Zg4ID8EYxuRCZbbuOK3ZSPNvVXY_tgItd9l6vgx0gbLQHq_9WnF3qc3-pBaWsnmb_w70_-K8jxqQHGw32PTj0Y9SqEbyR9bbR_X_AlR-Dy2_TlVKUi2l1Va7cUSb4GAN2hyQV1dvB6zz43DvvdR585u_9Gf9A7yed9Qd7HaKBvgvgjI0HrKZK8in_3dbmb_H9IEO40FIxJfT7LzPNz-Yf371tGv0m8493fDus_pPwJ71E1fw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770458128</pqid></control><display><type>article</type><title>Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum</title><source>PubMed Central</source><creator>Ikeda, S ; Chisuwa, H ; Kawasaki, S ; Ozawa, J ; Hoshii, Y ; Yokota, T ; Aoi, T</creator><creatorcontrib>Ikeda, S ; Chisuwa, H ; Kawasaki, S ; Ozawa, J ; Hoshii, Y ; Yokota, T ; Aoi, T</creatorcontrib><description>A case is reported of a 21 year old woman who suffered from Castleman's disease and systemic reactive amyloidosis. The serum concentrations of serum amyloid A (SAA) and interleukin 6 (IL-6) were extremely high and amyloid protein was immunohistochemically identified as AA. After surgical excision of a large retroperitoneal lymph node with the pathological findings of plasma cell type of Castleman's disease, both serum SAA and IL-6 declined, showing a similar pattern of reduction curves. All clinical symptoms and laboratory abnormalities greatly improved. The biochemical feature of Castleman's disease is abnormal production of IL-6 and this cytokine continuously may stimulate the synthesis of an amyloid precursor, SAA, causing systemic reactive (AA) amyloidosis. This pathogenetic theory is strongly supported by the present study.</description><identifier>ISSN: 0021-9746</identifier><identifier>EISSN: 1472-4146</identifier><identifier>DOI: 10.1136/jcp.50.11.965</identifier><identifier>PMID: 9462253</identifier><identifier>CODEN: JCPAAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><subject>Adult ; Amyloidosis - blood ; Amyloidosis - etiology ; Biological and medical sciences ; Castleman Disease - blood ; Castleman Disease - complications ; Castleman Disease - pathology ; Female ; Hematologic and hematopoietic diseases ; Humans ; Interleukin-6 - blood ; Medical sciences ; Other diseases. Hematologic involvement in other diseases ; Serum Amyloid A Protein - metabolism</subject><ispartof>Journal of clinical pathology, 1997-11, Vol.50 (11), p.965-967</ispartof><rights>1998 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Nov 1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b509t-23cf05c46f4bf2c5f750345b203f69c5e6507cae3839e54aa49736d5f2cbff473</citedby><cites>FETCH-LOGICAL-b509t-23cf05c46f4bf2c5f750345b203f69c5e6507cae3839e54aa49736d5f2cbff473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC500328/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC500328/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2076484$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9462253$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ikeda, S</creatorcontrib><creatorcontrib>Chisuwa, H</creatorcontrib><creatorcontrib>Kawasaki, S</creatorcontrib><creatorcontrib>Ozawa, J</creatorcontrib><creatorcontrib>Hoshii, Y</creatorcontrib><creatorcontrib>Yokota, T</creatorcontrib><creatorcontrib>Aoi, T</creatorcontrib><title>Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum</title><title>Journal of clinical pathology</title><addtitle>J Clin Pathol</addtitle><description>A case is reported of a 21 year old woman who suffered from Castleman's disease and systemic reactive amyloidosis. The serum concentrations of serum amyloid A (SAA) and interleukin 6 (IL-6) were extremely high and amyloid protein was immunohistochemically identified as AA. After surgical excision of a large retroperitoneal lymph node with the pathological findings of plasma cell type of Castleman's disease, both serum SAA and IL-6 declined, showing a similar pattern of reduction curves. All clinical symptoms and laboratory abnormalities greatly improved. The biochemical feature of Castleman's disease is abnormal production of IL-6 and this cytokine continuously may stimulate the synthesis of an amyloid precursor, SAA, causing systemic reactive (AA) amyloidosis. This pathogenetic theory is strongly supported by the present study.</description><subject>Adult</subject><subject>Amyloidosis - blood</subject><subject>Amyloidosis - etiology</subject><subject>Biological and medical sciences</subject><subject>Castleman Disease - blood</subject><subject>Castleman Disease - complications</subject><subject>Castleman Disease - pathology</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Interleukin-6 - blood</subject><subject>Medical sciences</subject><subject>Other diseases. Hematologic involvement in other diseases</subject><subject>Serum Amyloid A Protein - metabolism</subject><issn>0021-9746</issn><issn>1472-4146</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkkuP0zAUhSMEGoaBJUskSyBgk-LErwaJxajiXUCCga11495M3UnsYjsD_Tn8U9xpKY8NKz_Od-491nVR3K3opKqYfLIy64nY7ieNFNeK44qruuQVl9eLY0rrqmwUlzeLWzGuKK2YqthRcdRwWdeCHRc_Pm1iwsEaEhBMspdIYNj03i58tJFAjN5YSLgg32xakhnE1OMA7lEkCxsRIj4lEYOFnpgluHOMxHckLZEY7wy6FCBZ765uwYwJyXqZTVvPOPxqRU4JuAWxLmHocbywjsh82kG3ixsd9BHv7NeT4vOL52ezV-X8w8vXs9N52QrapLJmpqPCcNnxtquN6JSgjIu2pqyTjREoBVUGkE1Zg4ID8EYxuRCZbbuOK3ZSPNvVXY_tgItd9l6vgx0gbLQHq_9WnF3qc3-pBaWsnmb_w70_-K8jxqQHGw32PTj0Y9SqEbyR9bbR_X_AlR-Dy2_TlVKUi2l1Va7cUSb4GAN2hyQV1dvB6zz43DvvdR585u_9Gf9A7yed9Qd7HaKBvgvgjI0HrKZK8in_3dbmb_H9IEO40FIxJfT7LzPNz-Yf371tGv0m8493fDus_pPwJ71E1fw</recordid><startdate>19971101</startdate><enddate>19971101</enddate><creator>Ikeda, S</creator><creator>Chisuwa, H</creator><creator>Kawasaki, S</creator><creator>Ozawa, J</creator><creator>Hoshii, Y</creator><creator>Yokota, T</creator><creator>Aoi, T</creator><general>BMJ Publishing Group Ltd and Association of Clinical Pathologists</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19971101</creationdate><title>Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum</title><author>Ikeda, S ; Chisuwa, H ; Kawasaki, S ; Ozawa, J ; Hoshii, Y ; Yokota, T ; Aoi, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b509t-23cf05c46f4bf2c5f750345b203f69c5e6507cae3839e54aa49736d5f2cbff473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adult</topic><topic>Amyloidosis - blood</topic><topic>Amyloidosis - etiology</topic><topic>Biological and medical sciences</topic><topic>Castleman Disease - blood</topic><topic>Castleman Disease - complications</topic><topic>Castleman Disease - pathology</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Interleukin-6 - blood</topic><topic>Medical sciences</topic><topic>Other diseases. Hematologic involvement in other diseases</topic><topic>Serum Amyloid A Protein - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ikeda, S</creatorcontrib><creatorcontrib>Chisuwa, H</creatorcontrib><creatorcontrib>Kawasaki, S</creatorcontrib><creatorcontrib>Ozawa, J</creatorcontrib><creatorcontrib>Hoshii, Y</creatorcontrib><creatorcontrib>Yokota, T</creatorcontrib><creatorcontrib>Aoi, T</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ikeda, S</au><au>Chisuwa, H</au><au>Kawasaki, S</au><au>Ozawa, J</au><au>Hoshii, Y</au><au>Yokota, T</au><au>Aoi, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum</atitle><jtitle>Journal of clinical pathology</jtitle><addtitle>J Clin Pathol</addtitle><date>1997-11-01</date><risdate>1997</risdate><volume>50</volume><issue>11</issue><spage>965</spage><epage>967</epage><pages>965-967</pages><issn>0021-9746</issn><eissn>1472-4146</eissn><coden>JCPAAK</coden><abstract>A case is reported of a 21 year old woman who suffered from Castleman's disease and systemic reactive amyloidosis. The serum concentrations of serum amyloid A (SAA) and interleukin 6 (IL-6) were extremely high and amyloid protein was immunohistochemically identified as AA. After surgical excision of a large retroperitoneal lymph node with the pathological findings of plasma cell type of Castleman's disease, both serum SAA and IL-6 declined, showing a similar pattern of reduction curves. All clinical symptoms and laboratory abnormalities greatly improved. The biochemical feature of Castleman's disease is abnormal production of IL-6 and this cytokine continuously may stimulate the synthesis of an amyloid precursor, SAA, causing systemic reactive (AA) amyloidosis. This pathogenetic theory is strongly supported by the present study.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Association of Clinical Pathologists</pub><pmid>9462253</pmid><doi>10.1136/jcp.50.11.965</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9746
ispartof Journal of clinical pathology, 1997-11, Vol.50 (11), p.965-967
issn 0021-9746
1472-4146
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_500328
source PubMed Central
subjects Adult
Amyloidosis - blood
Amyloidosis - etiology
Biological and medical sciences
Castleman Disease - blood
Castleman Disease - complications
Castleman Disease - pathology
Female
Hematologic and hematopoietic diseases
Humans
Interleukin-6 - blood
Medical sciences
Other diseases. Hematologic involvement in other diseases
Serum Amyloid A Protein - metabolism
title Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T15%3A02%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systemic%20reactive%20amyloidosis%20associated%20with%20Castleman's%20disease:%20serial%20changes%20of%20the%20concentrations%20of%20acute%20phase%20serum%20amyloid%20A%20and%20interleukin%206%20in%20serum&rft.jtitle=Journal%20of%20clinical%20pathology&rft.au=Ikeda,%20S&rft.date=1997-11-01&rft.volume=50&rft.issue=11&rft.spage=965&rft.epage=967&rft.pages=965-967&rft.issn=0021-9746&rft.eissn=1472-4146&rft.coden=JCPAAK&rft_id=info:doi/10.1136/jcp.50.11.965&rft_dat=%3Cproquest_pubme%3E3971438511%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b509t-23cf05c46f4bf2c5f750345b203f69c5e6507cae3839e54aa49736d5f2cbff473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1770458128&rft_id=info:pmid/9462253&rfr_iscdi=true